CD7 CAR T-cell therapy, stem-cell transplant beneficial for CD7-positive tumors
For patients with relapsed or refractory CD7-positive leukemia or lymphoma, sequential CD7 chimeric antigen receptor (CAR) T-cell therapy followed by haploidentical hematopoietic stem-cell transplantation (HSCT) is safe and ...
1 hour ago
0
0
Researchers create an AI-powered digital imaging system to speed up cancer biopsy results
University of Waterloo researchers have invented a digital medical imaging system that significantly improves the cancer detection process to deliver immediate results and enable swift, effective treatment for all types of ...
3 hours ago
0
5
Mortality up for breast cancer diagnosed five to 10 years after childbirth
Young-onset breast cancer (YOBC) with germline BRCA pathogenic variants (PVs) is associated with an increased risk for all-cause mortality if diagnosed within 10 years after childbirth, according to a study published online ...
1 hour ago
0
0
Study reveals tai chi benefits for sleep quality in advanced lung cancer patients
A research team from the School of Nursing, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), found positive effects of tai chi and aerobic exercise on sleep quality, psychological well-being, physical function, ...
4 hours ago
0
16
A closed-loop drug-delivery system could improve chemotherapy
When cancer patients undergo chemotherapy, the dose of most drugs is calculated based on the patient's body surface area. This is estimated by plugging the patient's height and weight into an equation, dating to 1916, that ...
20 hours ago
0
19
New potential avenues for cancer therapies through RNA-binding proteins
A new paper describes the role of two RNA-binding proteins in the development of sarcoma and carcinoma cancers, highlighting the important and emerging role of RNA-binding proteins in cancer research and offering a new avenue ...
23 hours ago
0
2
Study highlights increased risk of second cancers among breast cancer survivors
Survivors of breast cancer are at significantly higher risk of developing second cancers, including endometrial and ovarian cancer for women and prostate cancer for men, according to new research studying data from almost ...
17 hours ago
0
7
Researchers identify novel gene networks associated with aggressive type of breast cancer
Breast cancer is the second-most common cancer diagnosis for U.S. women, and the second-leading cause of female cancer deaths. In recent years, breast cancer treatments have improved significantly, thanks to targeted gene ...
23 hours ago
0
0
Targeted use of enfortumab vedotin for the treatment of advanced urothelial carcinoma
An interdisciplinary research team has published new findings that indicate which patients with advanced urothelial carcinoma could benefit in particular from the new targeted therapy with the antibody-drug conjugate enfortumab ...
20 hours ago
0
1
Does ejaculating often reduce your risk of prostate cancer?
In terms of men's health issues, prostate cancer features high on the agenda. It's the second most diagnosed cancer in men globally—closely followed by lung cancer. And it's the most common cancer in men in the UK.
23 hours ago
0
2
Study reviews the role of a ribonucleic acid 'MALAT1' in hematological malignancies
Long non-coding ribonucleic acids (lncRNAs), despite not coding for any protein, can play a significant role in cancer formation, progression, and treatment outcomes. One such lncRNA of interest is MALAT1, abbreviated for ...
21 hours ago
0
0
Newly discovered mechanism helps tumor cells evade the immune system early on
Tumors actively prevent the formation of immune responses by cytotoxic T cells, which are essential in combating cancer. Researchers at the Technical University of Munich (TUM) and the Ludwig-Maximilians-Universität München ...
Apr 24, 2024
0
4
Mini-colons advance colorectal cancer research
In a breakthrough for cancer research, scientists at EPFL have created lab-grown mini-colons that can accurately mimic the development of colorectal tumors, offering a powerful new tool for studying and testing treatments ...
Apr 24, 2024
0
5
CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in clinical trial
Researchers at Texas Children's Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist have published results of a Phase I clinical trial of a ...
Apr 24, 2024
0
3
Discovering cancers of epigenetic origin without DNA mutation
A research team including scientists from the CNRS has discovered that cancer, one of the leading causes of death worldwide, can be caused entirely by epigenetic changes, in other words, changes that contribute to how gene ...
Apr 24, 2024
0
0
Study reveals insights into DDX41 protein's role in blood cancer pathogenesis
A study led by Professors Hongtae Kim and JaYil Lee from the Department of Biological Sciences, in collaboration with researchers from the Catholic University of Korea, sheds light on the pivotal role of mutated DDX41 protein ...
Apr 23, 2024
0
32
Liver cancer: Molecular signaling pathway of tumor development decoded
As a malignant disease of the liver cells, hepatocellular carcinoma (HCC) is one of the main causes of cancer-related deaths. While the treatment options for this aggressive type of cancer remain limited, the incidence is ...
Apr 23, 2024
0
10
A sustainable diagnosis tool for multiple cancers
An accurate, affordable, environmentally and user-friendly diagnostic tool for multiple cancers—including pancreatic, gastric, and colorectal cancers—is reported in a paper in Nature Sustainability. The tool can diagnose ...
Apr 23, 2024
0
8